Immunome (NASDAQ:IMNM) Stock, Unusual Options

Immunome

Overview

News

Earnings

Options

Analyst Ratings

Insider Trades

Short Interest

Stock Report

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

What's Going On With Immunome Shares Monday?

Comments

Immunome Unusual Options